Expert Insights

NAD+ Therapy: Benefits and Cost (2026 Guide)

A direct breakdown of what NAD+ therapy costs across every delivery method in 2026, what drives the price, and whether IV is actually worth the premium.

June 30, 2026 8 min read BioStackIQ Editorial
NAD+ Cost IV Therapy Longevity
Back to Expert Insights

NAD+ therapy costs between $40 and $800 per session depending on delivery method. Intramuscular (IM) injections run $40 to $300 per session, IV infusions run $250 to $800 per session, and oral or at-home subcutaneous options run $30 to $350 per month. A full initial protocol, including a loading phase of 4 to 8 sessions plus monthly maintenance, typically totals $2,400 to $6,000 in the first year for moderate users, with intensive IV-only protocols reaching $8,000 to $18,000 annually. Insurance does not cover NAD+ therapy in 2026, since it is classified as elective wellness treatment.

For a full comparison of how each delivery method actually affects bioavailability and onset, see our NAD+ IV vs Oral guide. For a clinic-by-clinic pricing breakdown, see the NAD+ IV therapy pricing guide. For SubQ and oral dosing protocols by goal, see the Best NAD+ Supplementation Protocol guide.

Cost by Delivery Method

Method Cost Session Length Notes
IV Infusion $250 to $800 per session 1.5 to 4 hours Some NYC/LA clinics run $600 to $1,500. Requires clinical supervision.
Intramuscular (IM) $40 to $300 per session Minutes No IV setup, lower overhead. Faster than IV in practice.
SubQ Self-Administered $15 to $40 per session Onset 30 to 60 min $105 to $350 per month with telehealth oversight.
Oral NMN/NR Precursors $30 to $150 per month Daily capsule Lowest cost, lowest bioavailability. Solid research base.

What Drives the Price

Geographic location pushes major metro pricing 25 to 50 percent higher than smaller cities. Dosage matters too: 250mg sessions cost less than 1,000mg sessions. Add-ons like B12, glutathione, or vitamin C typically add $50 to $200. Provider type plays a role, since med spas often charge 20 to 40 percent more than clinical practices. Package size helps: bundles of 4 to 10 sessions lower the per-session cost by 10 to 40 percent.

Practical note: Most people who start with IV therapy eventually shift to IM or SubQ for maintenance once the initial loading phase is complete. The per-session cost drops significantly and the logistics are much simpler, with comparable benefit for ongoing optimization versus acute loading.

Benefits

NAD+ is a coenzyme present in every cell, involved in energy metabolism, DNA repair, and sirtuin activation tied to cellular aging pathways. Reported benefits include increased energy, improved cognitive clarity, and support for recovery. NAD+ has also been studied in addiction recovery contexts. NAD+ levels decline with age, which is the physiological rationale behind supplementation.

Research reference: Braidy N, et al. "Age related changes in NAD+ metabolism, oxidative stress and Sirt1 activity in Wistar rats." PLoS ONE. 2011. PMID: 21559512.
Research reference: Birkmayer GD. "Coenzyme nicotinamide adenine dinucleotide: new therapeutic approach for improving dementia of the Alzheimer type." Ann Clin Lab Sci. 1996. PMID: 8669538.
Research reference: Penberthy WT, Tsunoda I. "The importance of NAD in multiple sclerosis." Curr Pharm Des. 2009. PMID: 19519434.

Is IV Worth the Premium Over SubQ or IM?

IV delivers NAD+ directly to the bloodstream within minutes with no absorption variability. SubQ and IM also reach the bloodstream, just over 30 to 60 minutes instead of minutes. For most people optimizing for cost and convenience without sacrificing benefit, SubQ or IM is the more efficient choice. IV makes more sense for acute, intensive protocols or when speed of onset specifically matters.

The cost difference is substantial. An IV loading phase of 6 sessions at $500 per session runs $3,000. The same loading volume via IM at $120 per session runs $720. Over a year of monthly maintenance, the gap widens further. Unless you have a specific clinical reason for IV speed of onset, IM or SubQ delivers most of the benefit at a fraction of the cost.

My Protocol

I use NAD+ as part of my own peptide stack, alongside BPC-157, TB-500, and Sermorelin, and I track it the same way I track everything else: dose, frequency, and how I actually feel week to week. I built BioStackIQ because I wanted a single place to see whether a protocol like this was actually working, not just whether I was sticking to it.

If you want to build a protocol that includes NAD+ alongside peptides or other compounds, the Protocol Builder will walk you through it. If you already have a stack, the Rate My Stack tool will score it across six categories including interactions, timing, and goal alignment.

References

Braidy N, et al. "Age related changes in NAD+ metabolism, oxidative stress and Sirt1 activity in Wistar rats." PLoS ONE. 2011. PMID: 21559512.
Birkmayer GD. "Coenzyme nicotinamide adenine dinucleotide: new therapeutic approach for improving dementia of the Alzheimer type." Ann Clin Lab Sci. 1996. PMID: 8669538.
Penberthy WT, Tsunoda I. "The importance of NAD in multiple sclerosis." Curr Pharm Des. 2009. PMID: 19519434.